Cefdinir Capsules 头孢地尼胶囊
Cefdinir Cefzon 头孢地尼
Cefdinir Granules 头孢地尼颗粒
Cefdinir Dispersible Tablets 头孢地尼分散片
Cefdinir Omnicef 头孢地尼
Cefdinir lactone 头孢地尼杂质I ; 头孢地尼内酯
Cefdinir Tablets 头孢地尼片
Cefdinir Related Compound A 头孢地尼相关物质A
Cefdinir Impurity B 头孢地尼杂质B
It isinevitable to study new antibiotics which are resistant toβ-lactamases. At the lastestβ-lactams antibiotics,cefdinir is acquired from the cefixime,It modified thecefixime's structure and compensate the third generation of cephalosporins'weakfunction to the Gram-negative bacteria.
头孢地尼为新一代β-内酰胺类抗生素，它是在头孢克肟的基础上进行结构修饰得到的，弥补了原有第三代头孢菌素对革兰氏阳性菌作用弱的缺点。
参考来源 - 头孢地尼分散片健康人体药动学和相对生物利用度研究·2,447,543篇论文数据，部分数据来源于NoteExpress
OBJECTIVE: To evaluate clinical curative effect and the safety of cefdinir.
目的：评价头孢地尼的临床疗效和安全性。
Objective To evaluate the bioequivalence of cefdinir dispersion tablets and reference capsules.
评价头孢地尼分散片与参比胶囊的生物等效性。
Results :The method was proved to be selective for separation of cefdinir, its by-products, degradation products and E -isomer.
结果：头孢地尼与其副产物、降解产物及E 异构体分离良好。
应用推荐